首页> 外国专利> 'method of inhibiting virus replication, compound, method of inhibiting cytomegalovirus replication, antiviral compound, use of a compound, pharmaceutical composition, pharmaceutical composition inhibiting virus and cytomegalovirus replication and antiviral pharmaceutical composition'

'method of inhibiting virus replication, compound, method of inhibiting cytomegalovirus replication, antiviral compound, use of a compound, pharmaceutical composition, pharmaceutical composition inhibiting virus and cytomegalovirus replication and antiviral pharmaceutical composition'

机译：“抑制病毒复制的方法，化合物，抑制巨细胞病毒复制的方法，抗病毒化合物，化合物的用途，药物组合物，抑制病毒和巨细胞病毒复制的药物组合物以及抗病毒药物组合物”

页面导航

摘要
著录项
相似文献

摘要

B "VIRUS REPLICATION INHIBITION METHOD, COMPOUND, CYTOMEGALOVIRUS REPLICATION INHIBITION METHOD, ANTIVIRAL COMPOUND, USE OF A COMPOUND, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION. invention relates to heterocyclic compounds that have antiviral activity. Specifically, Compounds of formula (I) in which B, W, X, Y, Q, R ~ 1 ~, R ~ 2 ~, R ~ 3 ~, R ~ 4 ~ en are as defined herein, are useful in therapy and prophylaxis of viral infections in mammals.

机译：“病毒复制抑制方法，化合物，巨细胞病毒复制抑制方法，抗病毒化合物，化合物的使用，药物组合物，药物组合物和药物组合物。本发明涉及具有抗病毒活性的杂环化合物。），其中B，W，X，Y，Q，R 1〜，R 2〜，R 3〜，R 4〜en如本文所定义，可用于治疗和预防哺乳动物中的病毒感染。 展开▼

著录项

公开/公告号BR9815166A

专利类型

公开/公告日2000-10-10

原文格式PDF

申请/专利权人 BIOCHEM PHARMA INC.;
展开▼

申请/专利号BR19989815166

发明设计人 JEAN BEDARD;ROBERT RANDO;JEAN-FRANCOIS LAVALLEE;GUY FALARDEAU;
展开▼

申请日1998-12-11

分类号A61K31/44;C07D513/04;C07D495/04;A61K31/47;A61K31/505;A61K31/535;A61K31/54;

国家 BR

入库时间 2022-08-22 01:57:05

相似文献

专利

外文文献

中文文献

1. 抑制膜病毒复制的药物,其生产方法,药物组合物和抑制病毒感染的方法 [P] . 中国专利： CN1819834A . 2006-08-16

2. 一组具有抑制HIV-1病毒复制活性的替诺福韦双酯化合物、制备方法及其药物用途 [P] . 中国专利： CN102786549B . 2013.07.03

3. compound, pharmaceutical composition, method for treating or preventing hepatitis c virus infection in a subject, method for treating, preventing or ameliorating one or more symptoms of a liver disease or disorder associated with hepatitis c virus infection in a subject , method for inhibiting replication of a virus in a host, method for inhibiting replication of a virus [P] . BR112012014899A2 . 2017-03-14

机译：化合物，药物组合物，在受试者中治疗或预防丙型肝炎病毒感染的方法，在受试者中治疗，预防或改善与丙型肝炎病毒感染有关的肝脏疾病或病症的一种或多种症状的方法，抑制丙型肝炎病毒复制的方法宿主中的病毒，抑制病毒复制的方法

4. compound, pharmaceutical composition, method for ameliorating or treating viral infection, for inhibiting virus replication or treating viral infection and uses effective amount of pharmaceutically acceptable compound or salt thereof or pharmaceutical composition [P] . BR112014014740A8 . 2017-07-04

机译：化合物，药物组合物，改善或治疗病毒感染，抑制病毒复制或治疗病毒感染的方法，并使用有效量的可药用化合物或其盐或药物组合物

5. compound, pharmaceutical composition, method for ameliorating or treating viral infection, for inhibiting virus replication or treating viral infection and uses effective amount of pharmaceutically acceptable compound or salt thereof or pharmaceutical composition [P] . BR112014014740A2 . 2017-06-13

机译：化合物，药物组合物，改善或治疗病毒感染，抑制病毒复制或治疗病毒感染的方法，并使用有效量的可药用化合物或其盐或药物组合物

1. Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virusinfection [J] . Hidekatsu Yanai 国际肝胆胰疾病杂志（英文版） . 2014,第005期

2. Kaempferol inhibits Pseudorabies virus replication in vitro through regulation of MAPKs and NF-κB signaling pathways [J] . CHEN Xu, ZOU Yuan-feng, LI Li-xia, 农业科学学报（英文版） . 2021,第008期

3. A novel cytomegalovirus protein interacts with the histone deacetylase-containing NuRD complex to alter cellular gene expression and promote virus replication [C] . Ileana M. Cristea, Scott S. Terhune, Nathaniel J. Moorman, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

4. Human cytomegalovirus inhibits interferon-stimulated antiviral and immunoregulatory responses by disrupting Jak-Stat signal transduction: A novel mechanism of cytomegalovirus persistence [D] . Miller, Daniel Matthew. 1998

5. The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase [O] . Thomas Goldner, Guy Hewlett, Nicole Ettischer, 2011

6. The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase ▿ [O] . Goldner, Thomas, Hewlett, Guy, Ettischer, Nicole, 2011

7. Compounds, Methods and Compositions Useful for the Treatment of Bovine Viral Diarrhea Virus (BVDV) Infection and Hepatitis C Virus (HCV) Infection. [R] . Dykstra, C. C., Givens, M. D., Stringfellow, D. A., 2005

1. Cost-effective method of siRNA preparation and its application to inhibit hepatitis B virus replication in HepG2 cells [J] . Zhi-KangQian Bao-QinXuan Tai-ShanMin Jian-FengXu LinLi Wei-DaHuang . 世界胃肠病学杂志：英文版 . 2005,第9期

2. A small yeast RNA inhibits HCV IRES mediated translation and inhibits replication of poliovirus in vivo [J] . Xue-Song Liang Jian-Qi Lian Yong-Xing Zhou Qing-He Nie Chun-Qiu Hao The center of diagnosis and treatment for infectious diseases of Tangdu Hospital of Military Medical University of PLAXi’an 710038Shaanxi ProvinceChina . 世界胃肠病学杂志：英文版 . 2003,第5期

3. Hepatitis C virus inhibitor synergism suggests multistepinteractions between heat-shock protein 90 and hepatitis Cvirus replication [J] . Naoko Kubota ,Masataka Nomoto ,Gi-Wook Hwang . 世界肝病学杂志：英文版（电子版） . 2016,第5期

4. 有关化合物、高分子化合物、组合物撰写方式的异同 [C] . 郑慧娟 . 2015年中华全国专利代理人协会年会暨第六届知识产权论坛 . 2015

5. 肿瘤药物研发的新思路:旧药新用及新化合物的筛选-吡喹酮的抗肿瘤新用途及纺缍体检验点抑制剂筛选方法的建立 [A] . 吴振华 . 2012